Patent application number | Description | Published |
20140358438 | METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR COLLABORATIVE PRESENTATION OF TRAVEL ROUTE INFORMATION - Provided herein is a method, apparatus and computer program product for the collaborative presentation of information relating to a travel route. In particular, the method may include providing for display of primary information on a display of a first device, providing for display of ancillary of information on a display of a second device, receiving location information at the first device, and updating the ancillary information provided for display on the display of the second device in response to receiving the location information at the first device. The primary information may include route-guidance information for a route. The ancillary information may include information associated with the route. The ancillary information may include additional information relative to the primary information. The ancillary information may include point-of-interest information along the route. | 12-04-2014 |
20140359520 | METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR GRAPHICALLY ENHANCING THE USER INTERFACE OF A DEVICE - Provided herein is a method, apparatus and computer program product for presenting information relating to two or more applications on a partitioned display of a device. In particular, the method of example embodiments may include partitioning, by a processor, a display into a first region and a second region, where the first region is associated with a first application and the second region is associated with a second application. The method may further include providing for display of the first application across the first region and the second region, providing for display of a notification related to the first application in the first region, and providing for display of a notification related to the second application in the second region. | 12-04-2014 |
Patent application number | Description | Published |
20080270769 | PROCESS FOR RUNNING PROGRAMS ON PROCESSORS AND CORRESPONDING PROCESSOR SYSTEM - Programs having a given instruction-set architecture are executed on a multiprocessor system comprising a plurality of processors, for example of a VLIW type, each of said processors being able to execute, at each processing cycle, a respective maximum number of instructions. The instructions are compiled as instruction words of given length executable on a first processor. At least some of the instruction words of given length are converted into modified-instruction words executable on a second processor. The operation of modifying comprises in turn at least one operation chosen in the group consisting of: splitting the instruction words into modified-instruction words; and entering no-operation instructions in the modified-instruction words. | 10-30-2008 |
20110069753 | METHODS AND SYSTEM FOR ENCODING/DECODING SIGNALS INCLUDING SCRAMBLING SPECTRAL REPRESENTATION AND DOWNSAMPLING - A method for encoding and decoding media signals, includes the operations of generating at a transmitting side multiple descriptions associated to data of the media signals through a downsampling operation performed on the data, and decoding at a receiving side the multiple descriptions for reconstructing the data by merging the multiple descriptions. The operation of generating multiple descriptions further includes the operations of obtaining a spectral representation of the data, including bands associated to different ranges, the bands being obtained by a suitable quantization operation and including at least one highly quantized band, that is subjected to a higher degree of quantization. A scrambling operation is performed on the spectral representation by moving the at least one highly quantized band to a different range, the scrambling operation being performed prior the downsampling operation. In decoding, a descrambling operation is performed before the merging operation on the multiple descriptions. | 03-24-2011 |
20130070861 | METHOD AND SYSTEM FOR THE TREATMENT OF MULTIPLE-DESCRIPTION SIGNALS, AND CORRESPONDING COMPUTER-PROGRAM PRODUCT - A processing system, such as typically a CPU, is used for converting a digital signal organized in pixels, such as a video signal, between a first format and a second multiple-description format. The system comprises at least one input register and at least one output register, and is configured via instructions, that can be constituted at least in part by instructions of a SIMD type, so as to: order the pixels of the signal to be converted in a set of input registers; and take selectively the pixels from the aforesaid set of input registers and place them in an orderly way in at least one output register. | 03-21-2013 |
Patent application number | Description | Published |
20100197670 | AMIDINE, THIOUREA AND GUANIDINE DERIVATIVES OF 2-AMINOBENZOTHIAZOLES AND AMINOBENZOTHIAZINES FOR THEIR USE AS PHARMACOLOGICAL AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE PATHOLOGIES - Amidine, thiourea and guanidine derivatives of appropriately substituted 2-aminobenzothiazoles, 2-amino-3,1-4H-benzothiazines and 3-amino-1,4-3H-benzothiazines, as understood from formula (I), the related pharmaceutically acceptable salts and solvates thereof: | 08-05-2010 |
20110182858 | SILIBININ COMPONENT FOR THE TREATMENT OF HEPATITIS - The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin | 07-28-2011 |
20120108825 | AMORPHOUS SILIBININ FOR THE TREATMENT OF VIRAL HEPATITIS - The invention relates to a method for the preparation of amorphous silibinin (or its synonyms: silybin or silibin) derived from a milk thistle fruit extract having an increased release rate and improved absorbability or bioavailability, and to the use of amorphous silibinin for the treatment or prevention of liver diseases, preferably for the treatment of viral hepatitis, e.g. hepatitis B or C, in particular in a patient who will undergo or has undergone liver transplantation. Preferably, the amorphous silibinin is adapted for oral administration. | 05-03-2012 |
20120142713 | CRYSTALLINE FORMS OF 6-(1H-IMIDAZOL-1-YL)-2-PHENYLQUINAZOLINE - The present invention relates to the solid state of 6-(1H-imidazol-1-yl)-2-phenylquinazoline (I) and therefore to novel crystalline forms of the base and of pharmaceutically acceptable salts and solvates thereof, and also to methods for preparing them, to the respective pharmaceutical formulations and to their therapeutic use. Compound (I) may be obtained as the free base in five different crystalline forms, three polymorphic forms and two hydrates. Some pharmaceutically acceptable salts of (I) that have physicochemical characteristics acceptable for pharmaceutical development were obtained, and the respective polymorphic forms and/or hydrates were characterized. | 06-07-2012 |
20120289478 | HYALURONIC ACID ESTERS, THEIR PREPARATION AND USE IN DERMATOLOGY - New ester derivatives of hyaluronic acid with hydroxy-cinnamic acid, their rheological and anti-radical properties are used as protective agents in dermatology. | 11-15-2012 |
20130165494 | 1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors - 1,5-diaryl-2-alkylpyrrole-3-substituted nitro esters, of Formula (I) | 06-27-2013 |
20130236420 | SILIBININ COMPONENT FOR THE TREATMENT OF HEPATITIS - The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin. | 09-12-2013 |
20140357653 | CHEMICAL COMPOUNDS - The invention relates to a novel compound of formula (I) or a stereoisomer, or a racemate or a mixture or a pharmaceutically acceptable salt thereof: wherein: R is phenyl or a 5- or 6-membered heteroaryl ring containing 1 to 3 heteroatoms selected from S, N and O, such rings may be optionally substituted with n groups Q; Q is selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN, SO | 12-04-2014 |
20150065523 | CHEMICAL COMPOUNDS - The present invention provides compounds of formula (I) including stereoisomers or a racemate or a mixture or a pharmaceutically acceptable salt thereof: wherein X is NH, or O; Q is 5-6 membered heteroaryl group, which may be substituted by one or more substituents independently selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN; A is phenyl or a 5-6 heteroaryl group, which may be substituted by one or more substituents independently selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN; B may assume different meanings from A and is phenyl or a 5-6 membered heteroaryl group, which may be substituted by one or more substituents independently selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN; and processes for their preparation, pharmaceutical compositions containing them and their use as dual antagonists of the Orexin 1 and Orexin 2 receptors. | 03-05-2015 |